Community/Retail

Established through a partnership of Parata Systems and Pharmacy Times, the Next-Generation Pharmacistâ„¢ program salutes pharmacy professionals in a variety of industry categories who are defining the future of pharmacy.

Baxter is recalling 1 lot of its 0.9% sodium chloride injection due to customer complaints of leaking containers, particulate matter, and missing port protectors, which could result in contamination.

Plastic surgeons make better stitches when they listen to their favorite music, according to new research.

The possibilities to promote the pharmacy profession are limitless.

The newly updated White House strategy to combat HIV/AIDS includes principles that are at the heart of managed care pharmacy practices.

As pharmacy schools graduate more and more pharmacists, the next 20 years of the pharmacy profession could see job placement challenges.

The FDA has approved anticonvulsant levetiracetam (Spritam) for the treatment of seizures in adults and children with epilepsy.

Pfizer Inc. today announced that the European Commission has approved under the European Union Merger Regulation the company's pending acquisition of Hospira, Inc.

Eli Lilly and Company today notified the University of California, San Diego of its intent to end its contract with the university for the management of the Anti-amyloid Treatment.

Patients are surfing the Internet to self-diagnose their symptoms more than ever.

Ken Martindale, the current president and chief operating officer of Rite Aid Corporation, has been promoted to the newly created position of CEO of Rite Aid stores.

Pfizer Inc. and Synthon today announced they have entered into an agreement whereby Pfizer has acquired the exclusive commercialization rights in the United States to glatiramer acetate.

Tyler Redelico, pharmacy student at Rutgers University's Ernest Mario School of Pharmacy, gives advice to students heading to pharmacy school.

Simon Lu, pharmacy student at Rutgers University's Ernest Mario School of Pharmacy, shares a fun fact he learned in pharmacy school.

Repeated requests for early refills may be a sign that a medication is being misused or diverted.

The better educated the patient, the better medicated the patient will be.

Do you carefully examine the explanation of benefits forms that you receive from your health insurer?

Novartis today announced that it has completed effective July 31, 2015 the divestiture of its influenza vaccine unit to CSL Limited.

Current medication regimens used in bipolar I disorder produce suboptimal patient outcomes more often than not.

The American Pharmacists Association Foundation today announced Elizabeth K. Keyes, BSPharm, will serve as Interim Executive Director for APhA Foundation.

Discount Drug Mart has opened its first MetroHealth walk-in clinic at the pharmacy chain's Parma Heights store, located at 6476 York Road.

Pharmacists should be aware that a clopidogrel tablet found in a bottle of hydrochlorothiazide tablets has prompted a product recall.

The term innovation is frequently used in today's lexicon. Whether it is used as a verb (to innovate) or an adjective to describe an activity (innovative), the term appears in all sectors of society.

Jamie Mitchell Mask, PharmD, a clinical community pharmacist consultant with Creative Pharmacist who still practices part time in Mendenhall, Missippi, joins the Show.

A man wearing a ninja mask and carrying a martial-arts sword recently robbed a Walgreens pharmacy in California.

RediClinic has announced that it will donate a total of $40,000 to 8 YMCAs serving the greater Baltimore/Washington DC, Philadelphia, and Seattle areas.

Will the new partnership between CVS Health and IBM bring about real disruption in community pharmacy?

Shire plc announced today that it has acquired New York-based, privately held Foresight Biotherapeutics Inc. for $300 million.

Teva Pharmaceutical Industries Ltd. and Immuneering Corporation announced that the companies have entered into an agreement in which Teva will purchase a 51% equity share of the company.

AstraZeneca and Isis Pharmaceuticals, Inc. today announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal diseases.